Back
Day Range
$103.56
$110.53
52-Week Range
$7.58
$120.32
Volume
836,037
50D / 200D Avg
$109.41
/
$69.66
Prev Close
$102.01
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -28.8 | 0.2 |
| P/B | 50.7 | 3.0 |
| ROE % | -163.8 | 3.6 |
| Net Margin % | -114962.3 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 1.9 | 0.2 |
Analyst Price Target
Hold
$108.75
-1.3%
Low: $77.00
High: $126.00
Forward EPS
-$4.02
Est. Revenue
55.30M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
$7.32
$2.68 – $12.94
|
1.05B | 4 |
| FY2028 |
$3.64
$2.26 – $5.29
|
700.61M | 6 |
| FY2027 |
-$0.30
-$3.18 – $4.65
|
356.59M | 9 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-25 | -$1.08 | -$0.97 | +9.9% |
| 2025-11-12 | -$1.02 | -$0.92 | +9.8% |
| 2025-08-14 | -$0.90 | -$1.04 | -15.6% |
| 2025-05-14 | -$0.95 | -$0.86 | +9.5% |
| 2025-03-31 | -$0.72 | -$0.85 | -18.1% |
| 2024-11-14 | -$0.65 | -$0.70 | -7.7% |
| 2024-08-14 | -$0.71 | -$0.62 | +12.7% |
| 2024-05-15 | -$0.71 | -$0.64 | +9.9% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Negative free cash flow of -83.72M
Capital intensive — 162.26% of revenue goes to capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-163.80%
ROIC-43.64%
Net Margin-114962.34%
Op. Margin-111812.99%
Safety
Debt / Equity
1.94
Current Ratio10.55
Interest Coverage4.75
Valuation
P/E Ratio
-28.81
Forward P/EN/A
P/B Ratio50.72
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 154,000.0 | Net Income (TTM) | -177.04M |
| ROE | -163.80% | ROA | -37.95% |
| Gross Margin | 50.00% | Operating Margin | -111812.99% |
| Net Margin | -114962.34% | Free Cash Flow (TTM) | -83.72M |
| ROIC | -43.64% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.94 | Current Ratio | 10.55 |
| Interest Coverage | 4.75 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -28.81 | Forward P/E | N/A |
| P/B Ratio | 50.72 | P/S Ratio | 33117.00 |
| PEG Ratio | -0.88 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 92.22 | Fwd Earnings Yield | N/A |
| FCF Yield | -1.64% | ||
| Market Cap | 5.10B | Enterprise Value | 5.13B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 154,000.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -177.04M | -111.78M | -63.78M | -40.37M | -29.61M |
| EPS (Diluted) | -3.78 | -2.83 | -2.69 | -2.68 | -2.28 |
| Gross Profit | 77,000.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -172.19M | -113.27M | -66.23M | -39.39M | -28.36M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 466.56M | 245.12M | 191.22M | 175.70M | 85.91M |
| Total Liabilities | 366.00M | 129.50M | 51.45M | 41.93M | 17.20M |
| Shareholders' Equity | 100.56M | 115.62M | 139.77M | 133.77M | 68.71M |
| Total Debt | 195.38M | 97.95M | 37.45M | 35.24M | 14.89M |
| Cash & Equivalents | 165.70M | 22.51M | 30.66M | 24.57M | 84.29M |
| Current Assets | 465.66M | 244.57M | 190.59M | 175.16M | 85.35M |
| Current Liabilities | 44.15M | 31.72M | 14.19M | 6.88M | 2.51M |